Medications are dispensed to patients with “liver cancer” through 22 units for the treatment of hepatitis viruses located in national institutes: ministry ...
Scientists at EPFL have developed "lymphomoids," a pioneering cancer model that preserves the structure and multicellular ...
Liver cancer rates have more than tripled in the U.S. since 1980 and continue to rise. More than 41,000 people will be ...
A MedUni Vienna study has identified a new approach to the drug treatment of metabolic liver diseases. In an experimental ...
It uses electromagnetic waves to target tumors and is available to patients for whom first- and second-line treatments have ...
A real-world study sought to measure survival outcomes against the results of a pivotal clinical trial on the effectiveness of durvalumab plus chemotherapy.
CAR T-cell therapy has revolutionized the treatment of certain blood cancers—including leukemias, lymphomas and multiple ...
Liver cancer rates have more than tripled in the U.S. since 1980 and continue to rise. More than 41,000 people will be ...
For many people with early breast cancer (eBC), remission doesn’t mean everything goes back to normal. There are scars from ...
From detecting early disease to guiding treatment plans, clinicians are finding ctDNA testing increasingly important.
A MedUni Vienna study has identified a new approach to the drug treatment of metabolic liver diseases. In an experimental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback